Chemours Company
Stock NYSE – Stock Market Prices, News & Analysis
The Chemours Company specializes in performance chemistry, producing chemicals used in cooling, emission reduction, and surface coatings.
Chemours Company
The Chemours Company specializes in performance chemistry, producing chemicals used in cooling, emission reduction, and surface coatings.
Price history of Chemours Company
Price history of Chemours Company
Performance & Momentum
Chemours Faces Account Probe and Advances Tech Partnership
Chemours (NYSE: CC) is under investigation by a securities law firm concerning a one-time inventory charge that impacted its recent earnings. Simultaneously, the company is progressing in a strategic partnership with 2CRSi to develop next-generation data center cooling technologies aimed at high-density IT infrastructure. This dual development presents a mix of legal risks and growth opportunities in high-value sustainable solutions.
Strategic Analysis
Chemours Company • 2026
Chemours Company positions itself in the performance chemicals segment with a portfolio focused on cooling chemicals, emission reduction, and surface coatings, addressing specific industrial needs and environmental challenges. Its specialization in high-value technical applications constitutes its niche in a competitive chemical market.
Strengths
- Recognized expertise in critical industrial chemical solutions
- Positioning in strategic markets related to the environmental transition
- Diversified product portfolio focused on high-performance chemistry
Weaknesses
- Persistent negative stock performance over several years
- Vulnerability to economic cycles and fluctuations in raw materials
Momentum
Current momentum, although positive, remains moderate and contrasts with the marked long-term downward trend, indicating a possible stabilization but without clear signs of a sustainable reversal. The absence of significant recent announcements reinforces the need for vigilance regarding the company's ability to convert this momentum into sustainable growth.
Recent News
Chemours Company
Mutual of America Cuts Stake in Chemours by 72%
7 months agoMutual of America Capital Management LLC reduced its stake in Chemours by 72.4% in the first quarter, signaling possible short-term concerns about the company's outlook. This significant fund withdrawal may partly explain recent market volatility despite the stock's notable recent rise. The large divestment points to a potentially bearish trend to watch.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases